17,195
edits
Changes
no edit summary
'''Types of Postmortem Chemotherapy'''
----
The '''postmortem chemotherapy''' regimens available are varied depending on the type of metastatic cancer that killed the patient.
'''Patient Selection for Postmortem Chemotherapy'''
----
Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but that they are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> Patients usually must undergo [[Transthoracic Echocardiogram|transthoracic echocardiogram]] (or [[Amazon Echocardiogram|TTE]]) in order to monitor for and avoid cardiotoxicity as is the case with doxorubicin-based '''postmortem chemotherapy''' regimens.
'''Drug Monitoring During Chemotherapy'''
----
Typically, decreased patients are given '''postmortem chemotherapy''' in the outpatient setting where skilled health care professionals look for the presence of [[Vital Signs|vital signs]].
'''Does It Work?'''
----
If '''postmortem chemotherapy''' continues its current rate of success, then , by the end of 2017 , 100% of decreased patients should remain dead.